MAPT and amyloidosis: The presence of suspected non-AD pathophysiology (SNAP; neurodegeneration in the absence of amyloid) [50] and primary age-related tauopathy (PART) in the absence of amyloid [51] illustrate the heterogeneity in the age-related neurodegenerative processes and share some pathophysiological aspects (neurodegeneration or tau) of the AD biomarker cascade.